4.3 Article

Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Biomarkers of endothelial dysfunction and atherosclerosis in hidradenitis suppurativa

Marcos A. Gonzalez-Lopez et al.

Summary: This study found that serum Ang-2 and ADMA levels are significantly increased in patients with HS, and Ang-2 may be a suitable marker of HS severity.

JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Disparate effects of adalimumab and fumaric acid esters on cardiovascular risk factors in psoriasis patients: results from a prospective, randomized, observer-blinded head-to-head trial

G. Holzer et al.

Summary: This study compared the effects of adalimumab and fumaric acid esters on cardiovascular disease markers in psoriasis patients. The results showed that adalimumab significantly improved FMD, while fumaric acid esters reduced total cholesterol levels.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Dermatology

Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life

T. Nguyen et al.

Summary: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that severely impairs patients' quality of life. Patients with HS often experience significant diagnostic delays and the symptoms can lead to a decrease in quality of life.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Pharmacology & Pharmacy

Do anti-tumour necrosis factor-α biologics affect subclinical measures of atherosclerosis and arteriosclerosis? A systematic review

Laurence Knowles et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Letter Dermatology

Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial

Rachel G. Casseres et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Review Immunology

An update on the pathogenesis of hidradenitis suppurativa: implications for therapy

Deborah Negus et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)

Article Dermatology

Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis

A. Martinez-Lopez et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Medicine, Research & Experimental

Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis

Ulf Bergstrom et al.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2018)

Article Dermatology

Assessment of subclinical atherosclerosis in hidradenitis suppurativa

J. C. Pascual et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Article Dermatology

Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS)

Marcos A. Gonzalez-Lopez et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Article Dermatology

Anti-TNF- therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study

T. Pina et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Medicine, General & Internal

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial

Alexa B. Kimball et al.

ANNALS OF INTERNAL MEDICINE (2012)

Article Medicine, General & Internal

Hidradenitis Suppurativa

Gregor B. E. Jemec

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients

Gianluigi Mazzoccoli et al.

INTERNAL AND EMERGENCY MEDICINE (2010)

Article Cardiac & Cardiovascular Systems

Inflammation and atherosclerosis

P Libby et al.

CIRCULATION (2002)